Congrats to @multiplylabs (YC S16) on their $75M Series B! They build robots that manufacture the ...
TL;DR · AI 摘要
Y Combinator on X: "Congrats to @multiplylabs YC S16 on their $75M Series B! They build robots that manufacture the worl...
核心要点
- 主题聚焦:Congrats to @multiplylabs YC S16 on their $75M S
- 来源:Y Combinator(@ycombinator),建议结合原文判断细节。
- AI 分析暂不可用,本条为保底评分与摘要。
Y Combinator on X: "Congrats to @multiplylabs (YC S16) on their $75M Series B! They build robots that manufacture the world's most complex drugs, including gene therapies and mRNA treatments. AI is speeding up drug discovery, but someone still has to physically make the medicines, and today that… / X
Y Combinator
@ycombinator
Congrats to
@
multiplylabs
(YC S16) on their $75M Series B! They build robots that manufacture the world's most complex drugs, including gene therapies and mRNA treatments. AI is speeding up drug discovery, but someone still has to physically make the medicines, and today that work mostly happens by hand. Manual production is slow, vulnerable to contamination, and can cost more than $1 million per dose for some gene therapies. Multiply's robots run that production inside facilities at AstraZeneca and Legend Biotech.
businessinsider.com/see-the-pitch-…
Here's the pitch deck a robotics startup used to raise $75 million to automate drug manufacturing.
From businessinsider.com
6:22 PM · Oct 6, 2026
·
46.5K
Views
29
25
295
110